0%
Daily Market Update
20-Oct-20251 min readvipin kumar

India says it’s narrowing the gap with the US on trade deal dispute – Daily Market Update 20th Oct 2025

Get a Smart Summary Instantly

Prompt copied

The two sides have narrowed their differences on trade-related matters, and there are no major differences between India and the US on trade issues, the person said.

Overview and Outlook

Global Stock Market Today

  • US equity markets settled higher over 0.50%.
  • European equity markets ended lower in range 0.18% to 1.85%.
  • Asian equity markets are trading with a positive bias.
  • GIFT Nifty is up by 220 points, Nifty futures likely to open around 25980 levels.

 

News highlights from across the globe

  • US market is not showing any signs of weakness heading into Monday’s trade, with futures trading with considerable gains.
  • Asian equity markets are trading higher on Monday following two consecutive weeks of declines as easing trade tensions between the world’s largest economies bolstered sentiment.
  • Oil prices remained steady after posting a third weekly decline as traders weighed signs of easing trade tensions between the US and China.

 

Important news updates from the domestic front

  • Reliance Industries Q2 FY26 (Cons, QoQ) revenue up 4.51% at Rs 2.55 lk cr versus Rs 2.43 lk crore. Ebitda  up 6.94% at Rs 45885 crore  versus Rs 42905 crore. Ebitda margin up 41 bps at 18.02% versus 17.61%. Net profit down 32.7%  at Rs 18165 crore versus Rs 26994 crore.
  • Reliance Jio Consol QoQ revenue up 3% at Rs 31857cr vs Rs 30882cr EBIDTA up 4% at Rs 17275cr vs Rs 16690cr Margins at 54.22% vs 54.04% up 18bps Net Profit up 4% at Rs 6972cr vs Rs 6711cr.
  • Dixon Technologies (India) Q2 Highlights (Consolidated, YoY) revenue up 28.8% to Rs 14,855.04 crore versus Rs 11,534.08 crore Net Profit up 72% to Rs 670.00 crore versus Rs 389.85 crore Ebitda up 32% to Rs 561.33 crore versus Rs 426.37 crore Margin at 3.8% versus 3.7%.
  • ICICI Bank Q2 Highlights (YoY) net profit up 5% at Rs 12,359 crore versus Rs 11,746 crore NII up 7% at Rs 21,529 crore versus Rs 20,075 crore Provisions down 41% at Rs 914 crore versus Rs 1,557 crore Gross NPA at 1.58% versus 1.67% (QoQ) Net NPA at 0.39% versus 0.41% (QoQ) Advances up 10.27% YoY at Rs 14.08 lakh crore Total deposits up 7.7% YoY at Rs 16.12 lakh crore.
  • HDFC Bank Q2 Highlights (YoY) Total deposits at Rs 28 lakh crore as of September 30, 2025, up 12% YoY Gross advances at Rs 27.7 lakh crore as of September 30, 2025, up 9.9% YoY Net profit up 11% at Rs 18,641 crore versus Rs 16,821 crore Net interest income up 5% at Rs 31,551 crore versus Rs 30,114 crore Provisions up 30% at Rs 3,501 crore versus Rs 2,700 crore Gross NPA at 1.24% versus 1.40% (QoQ).
  • Fortis Healthcare’s Northern TK Venture along with PAC 1 and 2 has announced an open offer to acquire 19.7 crore shares at an issue price of Rs 170 per share.
  • Natco Pharma reports that the Supreme Court dismisses Roche petition in the Risdiplam suit, stating the challenge by Roche is not maintainable.
  • Tata Power temporarily suspends operations at Mundra units to fix technical issues; the Mundra units are tentatively closed till November 30.
  • Marico enters into a pact to buy the remaining 46% stake of HW Wellness Solutions.
  • Dixon Tech appointed Saurabh Gupta as Additional Director in the capacity of Director of Finance for five years.
  • Hindalco Industries appointed Kopal Agrawal as CEO Aluminium Downstream effective Nov. 1; Nilesh Koul resigns as CEO Aluminium Downstream effective Oct. 31.
  • RVNL emerges as the lowest bidder for an order worth Rs 144 crore.
  • NTPC declares commercial operation of 95.75 MW capacity of Khavda-I solar PV project in Gujarat.
  • Hindustan Aeronautics inaugurates third production line of Light Combat Aircraft Tejas Mk1A and second production line of Turbo Trainer-40 at Nashik unit.

 

Nifty Overview & Outlook

Benchmark Nifty index ended the week on a stellar note at 25710 spot levels after gaining 125 on daily basis and 1.7% on a weekly basis.

Broader markets underperformed the benchmark as Mid and Small cap indices settled on a slightly negative note.

Performance on the sectoral front was mix. Nifty FMCG index was the top performer, rose 1.37% followed by Health care and Pharma index that rose 0.76% and 0.68% respectively. On the flip side, IT and Media index was the worst performer, down over 1.5% each.

Technically, Nifty index formed a big bullish candlestick on a weekly chart following a Triangle formation breakout on Oct 16, 2025 setting up targets around 26300 spot levels. Going ahead, we continue to maintain our bullish view on Nifty index and suggest traders to maintain buy on dips trading approach till it is holding above 25200 spot levels on closing basis.

 

Derivatives Overview & Outlook

Last Friday, Nifty and Banknifty futures sheded around 4% and 1.5% of open interest as short covering, while some long unwinding was observed in Midcapnifty futures that shed 1.8% of open interest whereas no significant activities was seen in Finnifty futures on open interest front.

Performance on the sectoral front was mix. Amongst them, Some long unwinding were seen among Chemical and Realty stocks, while majority of other indices down on short buildup.

On option front, put writing along with some call addition was seen at OTM strikes. Maximum positions are at 26000 CE followed by 25800 CE. On the put side maximium positions are at 25500 PE followed by 25000 PE.

 

Institutional Trading Activity

Last week, FIIs bought stocks worth Rs 6135 Cr in the cash segment, bought index futures worth Rs 3587 Cr and sold stocks futures worth Rs 4493 Cr. DIIs were net buyers in the cash segment to the tune of Rs 16247 Cr during the week.

 

Nifty Futures, Banknifty Futures and Finnifty Futures Key Levels

Nifty – Resistances 25850-26000; Supports 25600-25500

Banknifty – Resistances 57800-58000; Supports 57200-56800

Finnifty – Resistances 27650-27800; Supports 27400-27300

 

F&O Security in Ban Today:  SAMMAAN CAPITAL & RBL BANK

 

 

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates.

AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited, Lakshya Impex Private Limited and Launchpad Fintech Private Limited are associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection.

This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months.  GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months.

Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months. GCML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.

No material disciplinary action has been taken on GCML by any regulatory authority impacting Equity Research Analysis activities.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document.

Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.